Insiders · Profile

Pfost Dale R

Chief Executive Officer at Chemomab Therapeutics. Filing since 14 Mar 2022. CIK 0001394663

Company

Date

Role

Action

Amount

Of holding

14 Mar 2022

Chief Executive Officer

Bought

2,500

$9.94K

opened

1 decision on file.